$114.20 +4.10 (%) Medivation Inc - NASDAQ

Jun. 30, 2015 | 04:00 PM

Partner Headlines

  1. Medivation Voted Three Years in a Row Among Top Workplaces in the San Francisco Bay Area

    GuruFocus | Jun. 30, 2015 | 00:03AM EST
  2. UPDATE: Medivation, Astellas Report Enrollment of First Patients in Advanced Prostate Cancer

    Benzinga | Jun. 17, 2015 | 07:05AM EST
  3. New Enzalutamide Data in Triple-Negative Breast Cancer Presented at the 2015 American Society of Clinical Oncology Annual Meeting

    Benzinga | Jun. 1, 2015 | 17:02PM EST
  4. Stocks: A Soft Jump On Jobs Data; WhiteWave, Boeing, NXP Climb

    IBD | May. 8, 2015 | 10:49AM EST
  5. Top Drugmaker Profits Mixed

    IBD | May. 7, 2015 | 18:51PM EST
  6. Medivation, Jazz Q1 Reports Miss; Regeneron Beats

    IBD | May. 7, 2015 | 18:43PM EST
  7. Four Hot Stocks You'll Want To Keep On Your Radar

    IBD | Feb. 27, 2015 | 17:44PM EST
  8. Nasdaq, S&P 500 Hang Tough; Avago, Akorn Big Earnings Winners

    IBD | Feb. 26, 2015 | 12:12PM EST
  9. Medivation Tops Q4 Views On Strong Xtandi Results

    IBD | Feb. 26, 2015 | 09:56AM EST
  10. Stocks Mixed; United Therapeutics Jumps To New High

    IBD | Feb. 25, 2015 | 14:59PM EST
  11. Market Edges Higher, Unfazed By Weak HP Results

    IBD | Feb. 25, 2015 | 13:31PM EST
  12. Market's Resilience Is Noteworthy; More Breakouts Emerge

    IBD | Feb. 25, 2015 | 11:55AM EST
  13. Earnings Scheduled For February 25, 2015

    Benzinga | Feb. 25, 2015 | 04:07AM EST
  14. Stocks Show Small Losses; Merger Talk Lifts Discovery

    IBD | Feb. 23, 2015 | 15:05PM EST
  15. Stocks Quietly Lower; Domino's, Medivation Break Out

    IBD | Feb. 23, 2015 | 13:18PM EST
  16. Wedbush Weighs in on Medivation Following Phase II TERRAIN Study Results

    GuruFocus | Feb. 3, 2015 | 12:50PM EST
  17. Valeant Agrees To Buy Dendreon's Provenge

    IBD | Jan. 30, 2015 | 11:39AM EST
  18. Weekly CEO Sells Highlight: QAD Inc, Orbitz Worldwide Inc, Constellation Brands Inc, and ...

    GuruFocus | Jan. 25, 2015 | 23:19PM EST
  19. Enzalutamide Phase 2 Terrain Trial Demonstrated Statistically Significant Increase in PFS as ...

    GuruFocus | Jan. 22, 2015 | 11:05AM EST
  20. J&J Earnings Beat, But Sales, Guidance Miss Estimates

    IBD | Jan. 20, 2015 | 11:20AM EST
  21. Eli Lilly Has 'Turned The Corner,' Upgraded

    IBD | Jan. 15, 2015 | 11:02AM EST
  22. Biotechs Presenting At The J.P. Morgan Healthcare Conference: Day 1

    Benzinga | Jan. 12, 2015 | 08:55AM EST
  23. Barclays Analyst Sees Biotech FY15 EPS Growth Outstripping Market

    Benzinga | Jan. 6, 2015 | 12:21PM EST
  24. William Blair's Top BioPharmaceutical Stock Picks for Q1 2015

    GuruFocus | Dec. 23, 2014 | 14:47PM EST
  25. Newly Profitable Medivation Riding High On Drug Sales

    IBD | Nov. 28, 2014 | 17:20PM EST
  26. Chip Stocks, Biotechs Lead Another Nasdaq Rally

    IBD | Nov. 24, 2014 | 14:58PM EST
  27. Major Upgrades And Downgrades In Friday's Market Action

    Benzinga | Nov. 7, 2014 | 15:30PM EST
  28. Medivation Hits High After Q3 Earnings Beat

    IBD | Nov. 7, 2014 | 11:15AM EST
  29. Medivation Hits High After Q3 Earnings Beat

    IBD | Nov. 7, 2014 | 11:15AM EST
  30. Medivation and Astellas Announce Phase 3 Study of Enzalutamide in Men With High-Risk, ...

    GuruFocus | Oct. 31, 2014 | 01:02AM EST
  31. J&J Earnings Beat; Olysio Chatter Hits Gilead

    IBD | Oct. 14, 2014 | 11:54AM EST
  32. Consider Medivation for Your Portfolio

    FoxBusiness | Oct. 6, 2014 | 13:31PM EST
  33. Benzinga's Top Downgrades

    Benzinga | Sep. 24, 2014 | 08:52AM EST
  34. Goldman Sachs Downgrades Medivation To Neutral, Shares Drop

    Benzinga | Sep. 24, 2014 | 08:38AM EST
  35. These 3 Biotech Stocks Just Hit New Highs

    Benzinga | Sep. 22, 2014 | 13:31PM EST
  36. Fast Money Halftime Report Final Trade From September 12

    Benzinga | Sep. 12, 2014 | 22:04PM EST
  37. Medivation Eyes Blockbuster As Cancer Drug Gets An OK

    IBD | Sep. 11, 2014 | 17:41PM EST
  38. Stifel Raises Medivation Inc Price Target

    Benzinga | Sep. 11, 2014 | 08:32AM EST
  39. Stocks Hitting 52-Week Highs

    Benzinga | Sep. 10, 2014 | 10:05AM EST
  40. A Few Reasons Why Investors Should Consider Dendreon for Their Portfolio

    GuruFocus | Aug. 15, 2014 | 12:18PM EST
  41. Medivation Cancer Drug Fuels Beat, Swings To Profit

    IBD | Aug. 8, 2014 | 11:55AM EST
  42. Benzinga's Volume Movers

    Benzinga | Aug. 8, 2014 | 10:32AM EST
  43. Medivation Announces Change in Executive Management Team; Dawn Svoronos To Chief Commercial Officer

    Benzinga | Jul. 10, 2014 | 16:11PM EST
  44. Citi Sees Plenty Of Q2 Earnings Beats Ahead In Biotech Sector

    Benzinga | Jul. 3, 2014 | 12:26PM EST
  45. Aegis Capital Believes Seragon Deal Underscores Value In Medivation

    Benzinga | Jul. 2, 2014 | 10:28AM EST
  46. UPDATE: Stifel Reiterates On Medivation Following Prostate Cancer Survey

    Benzinga | Jun. 23, 2014 | 09:33AM EST
  47. Benzinga's Top Upgrades

    Benzinga | Jun. 19, 2014 | 07:46AM EST
  48. US Stock Futures Flat Ahead Of International Trade Data

    Benzinga | May. 6, 2014 | 07:29AM EST
  49. UPDATE: Canaccord Genuity Initiates Coverage on Medivation as Urologist Uptake is Unclear

    Benzinga | Apr. 16, 2014 | 09:45AM EST
  50. Morning Market Movers

    Benzinga | Apr. 1, 2014 | 09:43AM EST
Trading Center
×

You are using adblocking software

Want access to all of Investopedia? Add us to your “whitelist”
so you'll never miss a feature!